Thus, obesity results in damage to insulin signaling pathways, deficiencies in neuroplasticity, and insulin resistance, which then leads to type-II diabetes in the periphery and Alzheimer’s disease, which has been called type-III diabetes, in the CNS. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.